A new FDA-cleared treatment for post-traumatic stress disorder (PTSD) using personalized magnetic brain stimulation has reported a 68% remission rate in a clinical trial, offering a drug-free alternative for the approximately 6% of Americans who will experience PTSD in their lifetime.
organisation
U.S. Food and Drug Administration
US food and drug regulator